ReFineDR: Observational study of Routine ophthalmological tests of patients included in the two Phase 3 clinical trials, promoted by Bayer, FIDELIO and FIGARO to investigate the effect of Fineronone in delaying the progression of Retinop

COMMERCIAL POST AUTHORIZATION STUDY